1.590USD+3.92%Mkt Cap: 2.59M $P/E: —2d ago
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humaniz…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap2.59M $
Enterprise Value-4.31M $
Revenue (TTM)—
Gross Profit-59.00K $
Net Income (TTM)-26.39M $
Revenue/Share—
Last Price1.590 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees10
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS74638P1093
Valuation
P/E (Trailing)—
P/E (Forward)-1.56
PEG—
EV/EBITDA0.55
EV/Revenue—
P/S—
P/B0.13
EPS (TTM)-46.33
EPS (Forward)-1.01
52W Range
1.46072% of range1.640
52W High1.640 USD
52W Low1.460 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-271.63%
ROA-150.16%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.66M $
CapEx (TTM)3.00K $
FCF Margin—
FCF Yield-189.56%
Net Debt-5.97M $
Net Debt/EBITDA0.76
Balance Sheet
Debt/Equity0.03
Current Ratio3.70
Quick Ratio3.42
Book Value/Sh12.00 USD
Cash/Share5.621 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateAug 21, 2020
Splits
Last Split1:10
Split DateMar 2, 2026
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)17.00 USD
Upside (mean)+969.2%
Target Range17.00 USD – 17.00 USD
# Analysts1
Ownership
Shares Out.1.63M
Float1.08M
Insiders3.73%
Institutions7.10%
Short Interest
Short Ratio0.4d
Short % Float0.65%
Short % Out.0.65%
Shares Short10.53K
Short (prev mo.)27.09K
Technical
SMA 501.577 (+0.8%)
SMA 2004.548 (-65.0%)
Beta-0.54
S&P 52W Chg18.16%
Avg Vol (30d)19.81K
Avg Vol (10d)127.80K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—